107 related articles for article (PubMed ID: 1839532)
1. Pharmacokinetics of paroxetine in patients with cirrhosis.
Dalhoff K; Almdal TP; Bjerrum K; Keiding S; Mengel H; Lund J
Eur J Clin Pharmacol; 1991; 41(4):351-4. PubMed ID: 1839532
[TBL] [Abstract][Full Text] [Related]
2. A review of the metabolism and pharmacokinetics of paroxetine in man.
Kaye CM; Haddock RE; Langley PF; Mellows G; Tasker TC; Zussman BD; Greb WH
Acta Psychiatr Scand Suppl; 1989; 350():60-75. PubMed ID: 2530793
[TBL] [Abstract][Full Text] [Related]
3. The relationship between paroxetine and the sparteine oxidation polymorphism.
Sindrup SH; Brøsen K; Gram LF; Hallas J; Skjelbo E; Allen A; Allen GD; Cooper SM; Mellows G; Tasker TC
Clin Pharmacol Ther; 1992 Mar; 51(3):278-87. PubMed ID: 1531950
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism.
Sindrup SH; Brøsen K; Gram LF
Clin Pharmacol Ther; 1992 Mar; 51(3):288-95. PubMed ID: 1531951
[TBL] [Abstract][Full Text] [Related]
5. The effect of liver enzyme inhibition by cimetidine and enzyme induction by phenobarbitone on the pharmacokinetics of paroxetine.
Greb WH; Buscher G; Dierdorf HD; Köster FE; Wolf D; Mellows G
Acta Psychiatr Scand Suppl; 1989; 350():95-8. PubMed ID: 2530801
[No Abstract] [Full Text] [Related]
6. The pharmacokinetics of paroxetine in patients with liver cirrhosis.
Krastev Z; Terziivanov D; Vlahov V; Maleev A; Greb WH; Eckl KM; Dierdorf HD; Wolf D
Acta Psychiatr Scand Suppl; 1989; 350():91-2. PubMed ID: 2530799
[No Abstract] [Full Text] [Related]
7. The pharmacokinetics of paroxetine in elderly depressed patients.
Ghose K
Acta Psychiatr Scand Suppl; 1989; 350():87-8. PubMed ID: 2530797
[No Abstract] [Full Text] [Related]
8. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
[TBL] [Abstract][Full Text] [Related]
9. Buspirone pharmacokinetics in patients with cirrhosis.
Dalhoff K; Poulsen HE; Garred P; Placchi M; Gammans RE; Mayol RF; Pfeffer M
Br J Clin Pharmacol; 1987 Oct; 24(4):547-50. PubMed ID: 3689635
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin.
Bannister SJ; Houser VP; Hulse JD; Kisicki JC; Rasmussen JG
Acta Psychiatr Scand Suppl; 1989; 350():102-6. PubMed ID: 2530759
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of the selective serotonin reuptake inhibitors.
DeVane CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
Tasker TC; Kaye CM; Zussman BD; Link CG
Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
Spreux-Varoquaux O; Doll J; Dutot C; Grandjean N; Cordonnier P; Pays M; Andrieu J; Advenier C
Br J Clin Pharmacol; 1991 Sep; 32(3):399-401. PubMed ID: 1777378
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic dose titration study in adult and elderly depressed patients.
Hebenstreit GF; Fellerer K; Zöchling R; Zentz A; Dunbar GC
Acta Psychiatr Scand Suppl; 1989; 350():81-4. PubMed ID: 2530795
[No Abstract] [Full Text] [Related]
15. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of paroxetine in renal impairment.
Doyle GD; Laher M; Kelly JG; Byrne MM; Clarkson A; Zussman BD
Acta Psychiatr Scand Suppl; 1989; 350():89-90. PubMed ID: 2530798
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration.
van Harten J; Duchier J; Devissaguet JP; van Bemmel P; de Vries MH; Raghoebar M
Clin Pharmacokinet; 1993 Feb; 24(2):177-82. PubMed ID: 8453824
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of paroxetine in the elderly.
Bayer AJ; Roberts NA; Allen EA; Horan M; Routledge PA; Swift CG; Byrne MM; Clarkson A; Zussman BD
Acta Psychiatr Scand Suppl; 1989; 350():85-6. PubMed ID: 2530796
[No Abstract] [Full Text] [Related]
19. Paroxetine: pharmacokinetics, tolerance and depletion of blood 5-HT in man.
Lund J; Lomholt B; Fabricius J; Christensen JA; Bechgaard E
Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):289-95. PubMed ID: 433623
[TBL] [Abstract][Full Text] [Related]
20. Cimetidine kinetics and dynamics in patients with severe liver disease.
Villeneuve JP; Fortunet-Fouin H; Arsène D
Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
